AMPH vs CPT · P/E 12, rev $732.0M vs P/E 104, rev $7.1M
Amphastar P (AMPH) versus Camden Property Trust (CPT) — a side-by-side from cached financials, not a winner call.
Amphastar P (AMPH) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Camden Property Trust (CPT) is a reit - residential company listed on US.
Latest reported AMPH revenue for 2024-12-31 was $732.0M. Net income was $159.5M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. AMPH currently screens at market cap $880.1M and trailing P/E 12.0.
Latest reported CPT revenue for 2024-12-31 was $7.1M. Net income was $170.8M. Revenue was up 106.8% from 2023-12-31 to 2024-12-31. CPT currently screens at market cap $12.11B and trailing P/E 104.0.
AMPH currently screens at market cap $880.1M and trailing P/E 12.0. CPT currently screens at market cap $12.11B and trailing P/E 104.0.
Not investment advice. Open the AMPH and CPT stock pages for the full models.
Not investment advice.